Quench Medica is organized around development of a novel aerosol platform technology designed more efficiently to deliver medicine into deep areas of the lung with the objective of increasing efficacy in treating pulmonary airway diseases. With ease of use, this next-generation, highly performing, multi-dose, handheld nhaler to is designed significantly improve symptoms for asthma patients. Proprietary technology delivers medication preferentially to the small airways with high efficiency and avoids mouth-throat deposit. A novel carrier-free formulation and device design produces a highly-dispersible aerosol to deliver medication where it is most effective in order to provide maximum symptom control.
